| 1 |
31992334 | Hedgehog signaling promotes sorafenib resistance in hepatocellular carcinoma patient-derived organoids. | 2020 Jan 28 |
7 |
| 2 |
33199679 | Proteoglycan-4 is correlated with longer survival in HCC patients and enhances sorafenib and regorafenib effectiveness via CD44 in vitro. | 2020 Nov 16 |
1 |
| 3 |
29899840 | CD44 positive and sorafenib insensitive hepatocellular carcinomas respond to the ATP-competitive mTOR inhibitor INK128. | 2018 May 25 |
3 |
| 4 |
28627617 | Sorafenib controls the epithelial‑mesenchymal transition of ovarian cancer cells via EGF and the CD44‑HA signaling pathway in a cell type‑dependent manner. | 2017 Aug |
1 |
| 5 |
27461522 | Synergistic inhibition of characteristics of liver cancer stem-like cells with a combination of sorafenib and 8-bromo-7-methoxychrysin in SMMC-7721 cell line. | 2016 Sep |
1 |
| 6 |
25053293 | A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells. | 2015 Feb 15 |
3 |
| 7 |
23228386 | Dietary supplement hymecromone and sorafenib: a novel combination for the control of renal cell carcinoma. | 2013 Jul |
1 |
| 8 |
23314174 | The combination of sorafenib and radiation preferentially inhibits breast cancer stem cells by suppressing HIF-1α expression. | 2013 Mar |
1 |